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ABSTRACT
Objectives: Pharmacists and general practitioners
(GPs) face an increasing expectation to collaborate
interprofessionally on a number of healthcare issues,
including medication non-adherence. This study aimed
to propose a model of interprofessional collaboration
within the context of identifying and improving
medication non-adherence in primary care.
Setting: Primary care; Sydney, Australia.
Participants: 3 focus groups were conducted with
pharmacists (n=23) and 3 with GPs (n=22) working in
primary care.
Primary and secondary outcome measures:
Qualitative investigation of GP and pharmacist
interactions with each other, and specifically around
supporting their patients’ medication adherence. Audio-
recordings were transcribed verbatim and transcripts
thematically analysed using a combination of manual
and computer coding.
Results: 3 themes pertaining to interprofessional
collaboration were identified (1) frequency, (2)
co-collaborators and (3) nature of communication
which included 2 subthemes (method of
communication and type of communication). While the
frequency of interactions was low, the majority were
conducted by telephone. Interactions, especially those
conducted face-to-face, were positive. Only a few
related to patient non-adherence. The findings are
positioned within contemporary collaborative theory
and provide an accessible introduction to models of
interprofessional collaboration.
Conclusions: This work highlighted that successful
collaboration to improve medication adherence was
underpinned by shared paradigmatic perspectives and
trust, constructed through regular, face-to-face
interactions between pharmacists and GPs.
INTRODUCTION
Medication non-adherence remains a signifi-
cant issue for patients, prescribers and
healthcare systems across the globe.1
Interprofessional collaboration is a growing
trend that sees health practitioners from dif-
ferent backgrounds coming together to offer
patient services or interventions.2 3 Complex
interventions to improve adherence are
often based within a collaborative interpro-
fessional setting, yet little is known about
how the collaboration functions and the opi-
nions of those involved.1 4 Currently there-
fore there is no formal structure in primary
care to facilitate patient–prescriber collabor-
ation in identifying and addressing non-
adherence in patients on chronic therapy.
The only structured form of pharmacist
collaboration in Australia is seen in the
Home Medicines Review (HMR). An HMR
may be initiated for an at-risk patient by
referral from a general practitioner (GP) to
an accredited HMR pharmacist who then
visits the patient in their home to conduct an
Strengths and limitations of this study
▪ This study is the first to have qualitatively investi-
gated mediators of interprofessional collabor-
ation between community pharmacists and
general practitioners (GPs) to support patients’
adherence to medications in primary care.
▪ Secondary thematic analysis was carried out on
transcribed data without a priori knowledge of
the focus group discussions, and analysis was
conducted using a combination of manual and
computer coding to ensure robust data analysis.
▪ Participants were recruited via a market research
company from a pool of GPs and community
pharmacists who had agreed to take part in
research. The findings are limited in generalis-
ability to the broader pharmacist and GP
populations.
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interview during which the patients’ medicines are dis-
cussed and inspected. After the review, the pharmacist
prepares a report for the patient’s GP with recommen-
dations for improving medicine management. The
pharmacist and GP should discuss the findings in the
report, and the GP should develop a medicine manage-
ment plan for the patient. In practice, research has
shown that the final step of communication between
pharmacist and GP is often omitted. Moreover, the
accredited pharmacist conducting the review may be
independently contracted by the GP.5
Several conceptual models of interprofessional collab-
oration between physicians and pharmacists have been
developed.6–16 An American model of collaborative
working relationship was proposed by McDonough and
Doucette.6 Their model of collaboration describes
‘context characteristics’ that is, the environmental
setting of professional interactions, ‘individual character-
istics’ relating to the personality and demographics of
collaborators, and ‘exchange characteristics’ which
includes trustworthiness, roles, relationship initiations
and ‘norm development’.6 McDonough and Doucette’s
model was expanded by Bradley et al,7 based on qualita-
tive interviews with GPs and community pharmacists.
Their approach describes a multilayered model of inte-
gration, and stratifies collaborations according to seven
mediators (‘locality’, ‘service provision’, ‘trust’, ‘knowing
each other’, ‘communication’, ‘professional roles’ and
‘professional respect’). In Hudson’s model (cited in
Leathard (1994))9 four pillars of interprofessional col-
laboration are conceptualised and include ‘communica-
tion’, ‘coordination’, ‘co-location’ and ‘commissioning’.
Hudson argued that multiple levels of collaboration
existed between collaborators, with collaborators moving
through stages of collaboration. Hudson’s work dichoto-
mises collaboration in optimistic and pessimistic models,
concluding that ‘the scope of professional integration is
greater than tends to be assumed’ suggesting there are
many opportunities for collaboration.10 A model devel-
oped by Van et al11–14 describes collaboration from the
perspective of the pharmacist and physician, citing
‘interactional’, ‘environmental’ and ‘practitioner deter-
minants’ as predictors of collaboration and highlighting
the importance of frequent or historical interactions
during training years.
Hughes and McCann15 identified barriers to inter-
professional collaboration in Northern Ireland. They
identified a key barrier as the ‘shopkeeper’ image of
pharmacists, arguing that the conflict between provid-
ing health services and running a business limited the
willingness of GPs to collaborate with pharmacists. The
gatekeeping role of GP secretaries was also identified
as barrier to collaboration.15 A recent review by Bardet
et al17 concluded additional core determinants of
‘trust’, ‘perceptions and expectations of other health-
care professionals’ were essential for collaboration,
highlighting the importance of the physicians’ social
perception of the pharmacist. Howard et al16 identified
‘role expectation’ as an issue for family physicians and
pharmacists who took part in a trial in which they
worked together to optimise medicines management
for patients over 65 years. The professionals involved in
the trial had differing perspectives of what pharmacists
were able to do—suggesting shared perspectives
may be the key to developing trust and successful
collaboration.
As far as the authors are aware, models of interprofes-
sional collaboration have not been presented within the
context of improving medication adherence. A recent
review concluded that behavioural interventions deliv-
ered by multiprofessional teams ‘offered the best oppor-
tunity to improve adherence’.4 As such, this study aimed
to conceptualise a model of interprofessional collabor-
ation within the context of improving medication
adherence.
METHODS
A qualitative study using focus group discussions with
GPs and community pharmacists was undertaken to
address the study aim. The participants were registered
pharmacists in community practice and GPs, over the
age of 21 years and who spoke English fluently.
Recruitment
To maximise the number of respondents, community
pharmacists and GPs were recruited using a market
research company (J&S Research Services, Cremorne,
Australia). The company has a database of pharmacists
and GPs who have agreed to take part in research.
However, a response rate (ie, how many were contacted
and how many refused to participate) was not recorded
by the company. Participants were reimbursed for their
involvement in the focus groups at $150 for the pharma-
cists and $200 for GPs, based on current rates used by
the market research company. Forty-eight eligible parti-
cipants were recruited, with 45 participating in six focus
groups, between June 2013 and February 2014.
Participant demographics are shown in table 1.
Focus groups
Three focus groups were conducted with GPs and
three focus groups were conducted with pharmacists
working in primary care in Sydney, Australia. Each
focus group discussion consisted of 6–8 participants,
and lasted for approximately 1.5 h. Owing to the quali-
tative nature of this study, focus group discussions were
conducted until ‘theoretical data saturation’ had been
reached.18
Focus group discussions were conducted using a semi-
structured protocol to address the study aims (see online
supplementary appendix1). The broad topics covered in
the discussions included GPs’ and community pharma-
cists’ awareness and understanding of their patients’
adherence and non-adherence to medications,
current adherence interventions/services delivered by
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participants in their practice; and their experience of
and opinions about an interprofessional approach to
support adherence. The face and content validity of the
interview protocol was established through pretesting of
the protocol with a small sample of researchers who
were also pharmacists (n=3). Focus groups were con-
ducted by the researchers (KH (lead facilitator), PA, IK
and SMM), and handwritten notes were taken during
the focus groups (SMM). For the purposes of this study,
collaboration was defined as working together to identify
non-adherence and factors contributing to non-
adherence in patients on chronic therapy, and support-
ing their adherence to their medications.
Data analysis
Focus groups were audio-recorded with permission of
the participants, transcribed verbatim and transcripts
quality checked for accuracy. The validity of the findings
is embedded within the methodological approach to
the analysis. Secondary thematic analysis of the rich,
qualitative data was carried out without a priori knowl-
edge of the focus groups or primary analysis to ensure
validity, rigour and avoid bias. The secondary thematic
analysis was conducted by an independent researcher
(APR) who did not participate in the focus groups
using a combination of manual coding and NVivo V.10
computer software (QSR International: Melbourne,
Australia). Analysis was conducted using a typical
method of constant comparison to identify new codes
and merge similar ones.18 Similar codes were then clus-
tered together to form themes. Each theme was ana-
lysed within the context of current interprofessional
collaboration models outlined above, to identify similar-
ities and differences in terminology and concepts to
highlight which model and/or mediators functioned as
facilitators or barriers to collaboration to improve adher-
ence. Each participant attending each session was
assigned a code. For example, participants in each focus
group were coded as F1=female 1, F2=female 2,
M3=male 3 and so on.
RESULTS
A total of 45 respondents participated in the focus
groups (table 1), 22 GPs in three focus groups and a
further 23 pharmacists in another three focus groups.
Three main themes were identified as mediators of
interprofessional collaboration within the context of
improving adherence. Theme 1—frequency of contact,
describes the regularity with which professionals inter-
acted, which appeared to be influenced by patients
accessing ‘multiple pharmacists and multiple doctors’,
rather than a regular pharmacist and a regular doctor.
Theme 2—co-collaborators, relates to perceptions of the
credibility of collaborative partners, co-location and gate-
keeper issues. The final theme ‘nature of communica-
tion’ amalgamates two subthemes, (1) the method of
communication including written, electronic, telephone
or face-to-face, and (2) the type of communication,
reactive or proactive. Figure 1 shows the identified
themes (left) with the associated functions of successful
collaboration (in the middle) through engendering
shared perspectives.
Theme 1 —frequency of contact
Respondents described the frequency of interactions
with each other as critical to successful collaboration to
improve adherence. They believed there were insuffi-
cient collaborative interactions with their GP or pharma-
cist counterpart that were focused on clinical issues,
such as medication adherence. Participants also
reported that patients’ frequent access to a regular
pharmacist and a regular doctor was essential for health-
care professional collaboration to identify and intervene
where adherence issues were evident.
…I try to encourage them to at least have one pharma-
cist that knows their history, especially when they’ve got
chronic medical conditions that can advise them on this
and that and the other. And I know that pharmacist
is going to pick up the phone and call me. “[Name
of GP], do you realise Mrs Smith is taking this…”.
Focus group (FG)3 General Practitioner (GP) Male
(M)1
Like how do you monitor every single person who does
go into the door, and they don’t even know if they’re the
regular customers or notice if they’re regular customers,
yeah. You can’t…it is impossible to track, I think, adher-
ence even if you have meetings. Like what are you going
to talk about? My patients may not see you. Your patients
may not come to us. So really that only works if your
customers come and see us regularly. FG6 Pharmacist
(Ph) F2
Some respondents indicated they had good relations
with their local doctors or pharmacists that were
mediated by regular contact, and were willing to
Table 1 Participant demographics
n=45 GPs Pharmacists
Total 22 23
Female 12 13
Male 10 10
Spoke English as first
language (at home)
16 14
Language other than English
as first language
6 9
Born in Australia 8 12
Born overseas 14 11
Education level
Tertiary 3 Tertiary 11
BPharm 14 MBBS 9
MPharm 5 Bachelor 2
Missing 1
Working hours/week
Mean (±SD) 36.6 (±9.6) 43.0 (±10.8)
Median (IQR) 38 (34–44) 40 (35–50)
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collaborate with each other to improve patients’ adher-
ence to medications.
Well look, I’ve got a good relationship with the pharma-
cists that work around my area, notwithstanding that
sometimes they have a pharmacy…a different pharmacist
come[s] in and help[s] them out, but the ones that are
there regularly I know quite well and I’m quite happy to
pick up the phone and talk to them about patients’ pre-
scriptions and sometimes I will ring them and check to
see if they’ve actually been dispensed as the patient says
or tells me, just to double check. FG5 GP M1
…we have quite a close working relationship with the
doctors, say if I’ve done a MedsCheck [a face-to-face con-
sultation with a consumer, conducted by a pharmacist,
aimed at improving medication use] and part of it he will
do a referral letter I will also follow it up with a phone
call…After that I will tell the customer to come in and
then they might make the change once the customer is
there with them… FG2 Ph F6
The need for frequent interactions between patients
and healthcare professionals also applied to collabor-
ation with other medical professionals, such as specia-
lists, and primary healthcare teams, as well as with the
patient’s carer.
There is a mental health care team especially like the
Webster [dose administration aid] patients who are
young, who are on medication, [one] needs to look at
Figure 1 Model of interprofessional collaboration to identify and improve non-adherence.
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adherence quite closely. So the mental team is someone
who we would get in contact regularly if there’s any issues
so they will communicate which helps a lot dealing with
the customers. FG1 Ph F4
Overall, interactions between pharmacists and GPs
were infrequent and irregular, and predominantly
focused on issues not related to adherence.
I get calls from them fairly frequently when…I guess if
there’s a concern with the compliance with the medica-
tion or if they come in and there’s a long period
between say the finishing of one script packet and the
next one being dispensed—they’ll call me, but most of
the calls are…to be honest, most of the calls we get or I
get from pharmacists are pharmacists that don’t know the
patient. They’re just a new patient to them. ‘I just wanted
to make sure if this script is correct?’ That goes back to
my point about having a regular pharmacist. FG5 GP M1
However, when interactions were more frequent, GPs
and pharmacists shared similar perspectives and trusted
one another, demonstrated by becoming more comfort-
able communicating out of hours to ask for favours
based on mutual understanding. This enabled them to
address clinical issues collaboratively.
There’s [sic] a few other doctors that we do chat on a
regular basis to the point where they don’t want us to call
them doctors or by their surname. We have got each
other’s mobile phones [numbers]. It’s to the point where
they can call me on a Sunday night and can ask me for
something or do a favour for them. That’s the level it’s
gone to. FG6 Ph M2
Theme 2—co-collaborators
Credibility, co-location and gatekeepers were issues
that mediated with whom and when effective collabor-
ation could occur to improve adherence. For example,
GPs questioned the credibility of alternative healthcare
practitioners with different paradigmatic perspectives to
healthcare, such as naturopaths, whose healthcare per-
spective and approach differed from traditional western
medicine and did not consider them suitable collabora-
tors in patient care. It appeared that where pharmacists
and GPs did not share similar perspectives, about each
other’s roles and goals in relation to adherence, collab-
oration was more difficult as it lacked trust. As pharma-
cists and GPs were exposed to each other, through
co-location, perspectives were renegotiated and aligned
leading to shared perspectives and trust.
I would have to agree it would be with people that I felt
their qualifications were really legitimate, hard earned
and stood up. I would not want a collaboration with all
the others it’s just going to turn into a dog fight but it’s
going to turn into not a productive conversation in my
mind, I might be totally wrong but they’ll be coming
from there and we’ll be coming from here and I don’t
see much common ground ever being established
because they just want to promote their way—well that’s
as I see it anyway. FG4 GP F3
Overall, pharmacists were regarded as credible health-
care professionals by most of the GP participants.
Pharmacists took a broader view and reported multiple
co-collaborators as credible to identify and improve non-
adherence, including the patient and carers.
Pharmacists felt that given their more frequent contact
(theme 1) with the patient/carer that they could
perform, and were responsible for adopting, an inde-
pendent or gatekeeper role when collaborating to iden-
tify or improve adherence. They reported that they saw
patients on chronic therapy more frequently than other
healthcare professionals, including GPs. The impact this
has on the nature of communication between
co-collaborators is expanded on in theme 3.
If they don’t comply, they don’t adhere, they’re not even
seeing the doctor…If you talk to the patient directly it’s
more useful. Even talking to the carer, talking to the
sister, talking to the mother, talking to the son are much
more helpful because you have immediate impact. FG1
Ph M1
I totally agree with that like we need to have a good inter-
professional relationship even though we still need to
have a good relationship with our patients and our carers
and families… FG1 Ph F4
Collaboration was mediated by co-location and gate
keepers. From the GP participants’ perspective, their
gate keeping role had been significantly eroded with
patients collaborating independently with multiple prac-
titioners, therefore limiting the GP’s ability to collabor-
ate with ‘a pharmacist’ to identify and intervene with
non-adherence.
On the other hand, pharmacists felt that secretaries
acted as gatekeepers and reported experiences of inef-
fective collaboration.
A lot of the problem with the specialists is the reception-
ist. You can’t get past them. Seriously, they will not let
you speak to them. FG6 Ph F1
However, co-location was reported as a significant
facilitator of collaboration and overcoming access issues
to GPs. When gatekeeping secretaries inhibited collabor-
ation, the close proximity of the GP surgery allowed
gatekeepers to be bypassed.
Well there is one doctor just across the road from us. I
can never get access to him because like you said the
receptionist just blocks me, so one day I just went to the
doctor’s surgery and I actually knocked on the door, obvi-
ously after the patient came out. And the doctor actually
let me in and we had a sat down for about ten minutes
discussing the patient, so I bypassed that receptionist but
that’s only because he’s across the road. FG6 Ph M1
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Theme 3—nature of communication
A theme relating to both frequency of contact and
co-collaborators was the nature of communication. This
was characterised by two subthemes. Subtheme (1)
method of communication, relates to how
co-collaborators actually communicated. Multiple means
of communication were utilised for interprofessional col-
laboration. These included written, electronic, tele-
phonic and face-to-face. Participants reported written,
electronic communication as effective for minor or
routine interaction or information exchange, but all par-
ticipants supported face-to-face communication as best
for cultivating effective collaboration.
…if there is ever a problem they do actually come out of
their office, go to the pharmacy, face to face contact and
they say, “Can you make this up? Can you give me sugges-
tions?” And that definitely helps a lot… FG3 Ph F2.
Subtheme (2) type of communication emerged as
both professional groups reported a high incidence of
reactive communication, that is, contacting one another
when faced with a problem, and only few examples of
proactive communication, that is, routine meetings.
Reactive communication engendered a theme of
‘responsibility’ where pharmacists would contact GPs
reluctantly as from the pharmacists’ perspective adher-
ence issues were something pharmacists were respon-
sible for dealing with, leading to a reluctant nature of
communication with GPs.
It’s not very common that we contact the doctor about
their adherence at all. I mean imagine calling the doctor
and saying this person is not really compliant with their
medication. Then the next step the doctor is going to go
‘what do you want me to do about it’. I think it’s more so
our job description rather than the doctors job descrip-
tion to make sure they’re compliant. I mean obviously
we’re more accessible to them and when doctors give
them five repeats they’re not going to go back to the
doctor in six months’ time, so we see them more than
they see the doctor. FG6 Ph F2
The quote above illustrates the barrier to collaboration
that exists when pharmacists and GPs do not share the
same perspectives about roles and responsibilities for
improving patients’ adherence.
Interestingly, remuneration was raised as a potential
strategy. GP participants suggested that the availability of
remuneration would allow a dedicated interprofessional
adherence support strategy to be developed and imple-
mented in the community setting.
…I suppose one of the things would be if you got paid
for doing that then you could probably dedicate a bit
more time to it…So to be able to do the things that you
are talking about here if there was some form of reim-
bursement that could happen… FG2 GP M3
Participants suggested, rather than reactive communi-
cation, proactive interactions facilitated by local organi-
sations enabled collaboration due to their informal or
social, face-to-face nature.
I’m with what we call a Vietnamese Health Professional
Association which with doctors, dentists, allied health
pharmacists. And it’s an organisation that started up
since ‘89 and we have functions and things like that, so it
involves relationships with all these allied health profes-
sionals. I think to be in the area with all of them it helps
because you’ve got that good relationship between
healthcare professionals and an understanding. Now
working outside of their area it could be a bit difficult
because you don’t get in contact with them much, but I
find that very helpful and we do have a strong associ-
ation. FG1 Ph M2
If we had face to face and occasionally that does happen.
I’ve been to psychiatric meetings and there are chemists,
the local chemist has turned up, same with physios [sic]
and sports orthopaedic meetings. So that actually is a
good thing because you meet them face to face and I
think that personal touch does help you know to kind of
engender respect and credibility in the other person.
FG4 GP F1
The quote above demonstrates how exposure to one
another changes perspectives of credibility and respect,
building trust. When perspectives are aligned and
shared, GPs and pharmacists come to trust one
another’s ability to improve adherence, and collabor-
ation was described as being easier.
Using the themes above a model was constructed
(figure 1) to present how the identified codes interacted
and mediated interprofessional collaboration to improve
adherence (figures 2 and 3). The findings point towards
a process of socialisation between pharmacists and GPs,
where relationships and shared perspectives are socially
constructed, resulting in trust and facilitating collabor-
ation (see Discussion).
DISCUSSION
Overall, this study has indicated that from the perspec-
tives of pharmacists and GPs, successful collaboration was
characterised by regular, face-to-face proactive interac-
tions (figure 2) while poor collaboration occurred when
interactions were irregular and infrequent (figure 3).
The findings therefore support an interprofessional
model of collaboration that is mediated by regular,
face-to-face interactions. This appeared to be under-
pinned through trust, embodied as shared perspectives
of healthcare, adherence, professional roles and goals,
credibility and respect; influencing the nature and fre-
quency of communication. Participants reported written,
computer-aided communication might also be helpful
for collaboration where regular, face-to-face interaction is
not possible. Co-location enabled regular, face-to-face
relationship building, which facilitated conversation and
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exposure, allowing preconceived perspectives to be rene-
gotiated and trust developed. This enhanced communi-
cation and information exchange between the
professional groups, improving the identification of non-
adherence and enabling collaborative improvement strat-
egies to be implemented.
This work supports the model put forward by Bradley
et al,7 with its emphasis of the importance of ‘regularity’
in relation to pharmacist and GP interactions with each
other and patients. Without regular interaction, pharma-
cists and GPs reported difficulty in identifying non-
adherence through an unwillingness to share informa-
tion with co-collaborators or communicate. There are
several similarities between the mediators identified in
their model and those identified in this study, for
example, ‘locality’ or co-location of collaborators.7 8 This
study identified co-location as a strategy to bypass gate-
keepers and increase direct, face-to-face interaction.
The findings differ to work by Hudson,19 who argued
that there must be a ‘strategy of planning for joint
working’ between collaborators. However, this study
found that successful collaboration emerged organically
through formal and informal social interactions
mediated by co-location or professional organisations.
GPs in this study reported that collaboration would only
be successful with co-collaborators with similar ‘health
scientific backgrounds’ which they conceptualised as
‘credibility’ and underpinned by trust. This speaks to
McDonough and Doucette’s6 ‘norm development’
concept and Howard et al’s16 work which argued differ-
ences in ‘role expectation’ was a barrier to collaboration.
Shared perspectives and paradigmatic norms about
‘credibility’, ‘responsibility’ and ‘roles’ can be
renegotiated or changed through regular, social inter-
action.20 Other models describe better collaboration
from a sense of ‘knowing’ or trust, and report perceived
credibility ‘building over time’7 17 20 21 that concords
with the findings from this study.
Models developed from empiric data have also shown
that frequent exposure and interaction between profes-
sionals as ‘directly influencing’ collaboration, highlight-
ing the value of ‘pharmacist and physician contact
during training’.13 14 17 This supports our model as
face-to-face interactions during training could lead to
the construction of shared perspectives and trust.
Perceptions constructed through interaction might
also allow previously held perspectives to change and
trust to develop, overcoming barriers to collaboration
such as the ‘shopkeeper’ stereotype.15 GPs in this study
appeared to use ‘demarcation strategies’ in an ‘attempt
to reinforce medical dominance’ by denouncing the
qualifications, values and credibility of practitioners that
held a ‘different view of the world’ or when improving
adherence is linked to financial or commercial inter-
ests.7 15 From the pharmacists’ perspective, there was an
reluctance to contact GPs about non-adherence, adopt-
ing an apologetic tone and only contacting GPs as a
reaction to an error, with a perception that dealing with
adherence is not of interest to the GP. With increased
social interaction, reported as sharing mobile phone
numbers and contacting each other out of hours,
attending functions together and camaraderie, these
perspectives or ‘world views’ were able to change and
trust develop.
Pharmacists and GPs in this study reported the best
collaboration to improve adherence took place when
Figure 2 Facilitators of
successful collaboration to
identify and improve
non-adherence.
Figure 3 Barriers to successful
collaboration to identify and
improve non-adherence.
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informal interactions occurred between the two profes-
sional groups regularly. As pharmacists and GPs engaged
in informal, face-to-face and regular interaction, colla-
borations organically emerged as trust was developed as
perceptions were changed and shared. This study theo-
rises that shared perspectives and trust constructed
through regular, face-to-face interaction, embedded by
co-location, is essential for successful interprofessional
collaboration to improve adherence.
In light of recent funding arrangements in the UK
and proposals in Australia that will attempt to co-locate
pharmacists in GP surgeries,22 23 this work provides a
theoretical basis for applications by clinicians, other
healthcare professionals or researchers seeking funding.
This work also offers practitioners insight into the func-
tions of collaboration. The findings may be transferable
to other settings and impact approaches to collabora-
tions between other professional groups in primary or
secondary care. Quantitative methods should be used to
investigate the use of the conceptualised model as a the-
oretical framework underpinning interventions for
increased and improved interprofessional collaboration
to support adherence.
Limitations
In interpreting the findings, it should be noted that
due to the qualitative nature of the study, the results
may not be generalisable to a broader population of
pharmacists and physicians, specifically those in a rural
setting (as the participants in the study worked in a
metropolitan area). Furthermore, a convenience sam-
pling and recruitment process was utilised, which
together with the reimbursement provided during the
study, may imply that a biased sample may have partici-
pated in the focus groups. However, the recruitment
ensured that there were approximately equal numbers
of GPs and pharmacists of both genders who worked in
a range of sociodemographic areas. Additionally,
data collected were self-reported, and as such are
limited by the accuracy of information provided by the
respondents.
CONCLUSION
This work presents a novel conceptualisation of media-
tors of interprofessional collaboration to support
patients’ adherence to medications. Adherence-related
interactions between community pharmacists and GPs
do exist, but they are infrequent and limited.
Pharmacists and GPs should attempt to develop regular,
face-to-face interactions with each other to foster success-
ful interprofessional collaboration. These findings may
be transferable to different settings, such as collabora-
tions between other healthcare professionals targeting
different interventions.
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